ABSTRACT
INTRODUCTION
Glucose is a simple energy substrate and important in fetal growth and development. The association between maternal hyperglycemia in pregnancies with gestational diabetes and fetal macrosomia, operative deliveries, shoulder dystocia, and poor fetal outcome is well known. Small for gestational age (SGA) fetuses make up 3 to 10% of pregnancies. Maternal hypoglycemia has been reported to be linked with both intrauterine growth restriction and poor neonatal outcome. Abell The aim of the study was to determine if pregnancies with low plasma sugar following a 50 gm oral glucose challenge test were at increased risk of having SGA neonate and adverse neonatal outcome.
MATERIALS AND METHODS
This study was an observational cohort study done from August 2008 to September 2010 at a tertiary referral centre. Antenatal women without risk factors for diabetes were screened for gestational diabetes with a 50 g glucose challenge test between 24 and 28 weeks of gestation. Venous blood was collected one hour after ingestion of glucose irrespective of the last meal. Tests were performed using glucose oxidase-peroxidase based method. All low risk singleton pregnancies with excellent dating with glucose challenge taste (GCT) ≤139 mg/dl, who delivered at term, were included in the study. Women with preexisting medical conditions, such as hypertension, cardiac disease, bronchial asthma and thyroid disorder and those with fetal anomalies were excluded from the study. There were 450 women who were divided into two groups based on the GCT values. Low GCT in our study was defined as ≤88 mg/dl (≤5th percentile). There were 150 women with GCT ≤88 mg/dl (subjects/cases). These 150 cases were matched with 300 randomly selected controls who had GCT values between 89 to 139 mg/dl with similar inclusion and exclusion criteria.
Outcome measures studied were birth weight, NICU admission and mortality. SGA is defined birth weight less than the 10th percentile. In our study, 2.5 kg was the 10th percentile. Hence, birth weight of ≤2.49 kg was taken as SGA and birth weight ≥2.5 kg was taken as normal. The data were analyzed using the statistical package for the social sciences 11.5. The comparison of outcomes among the two groups was done by Chi-square test, Student's t-test, Mann-Whitney test and post-hoc test, wherever applicable. A p-value of <0.05 was considered statistically significant. Table 1 shows comparison of known independent risk factors for SGA, such as age, parity, socioeconomic status, body mass index, interval between pregnancies,
RESULTS
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IJIFM mean weight gain, presence of anemia (hemoglobin percent) and gestational age at delivery between subject and control groups. The differences were not statistically significant, therefore, were matched.
The overall incidence of SGA in our study was 10.7% (48/450). The incidence of SGA in the low GCT group was 17.3% (26/150) and, in the normal GCT group was 7.3% (22/300). p-value was significant. The odds ratio was 2.65, indicating that women with low GCT are 2.65 times at higher risk of having SGA babies than women with normal GCT ( Table 2) .
The mean birth weight in women with GCT <70 mg/dl, 71 to 80 mg/dl and 81 to 88 mg/dl was 2.60 ± 0.843 kg, 2.67 ± 0.756 kg and 2.80 ± 0.598 kg respectively. Though the p-value was not significant as the GCT values increased a rising trend in the birth weight was observed.
Neonates who got admitted in intensive care unit in the low GCT group were 24.7% (37/150), and in the normal GCT group were 17.7% (53/300). The NICU admissions were more in low GCT group but the p-value was not significant. The NICU admissions among the SGA neonates of both the groups were 35.4% (17/48) and among the appropriate for gestational age (AGA) neonates were 18.2% (73/402). The p-value (0.007) was significant. Table 3 shows that 34.6% (9/26) of SGA neonates of low GCT group and 36.4% (8/22) of SGA neonates of normal GCT group required NICU admission. Small for gestational age neonates of both groups were at higher risk for NICU admission.
Reasons for NICU admissions in both the groups include hypoglycemia, respiratory distress syndrome, sepsis, seizures and hyperbilirubinemia. Among various neonatal morbidities, neonatal hypoglycemia and related consequences, like seizures, are expected to be more in low GCT group, but the differences were either statistically not significant or too small a number to come to a conclusion.
There was one neonatal death in each group. The baby in the study group had diffuse muscular dystrophy and, in the control group, the cause of death was pneumonia and metabolic acidosis. 
DISCUSSION
The placental transfer of glucose is dependent upon maternal plasma glucose, uterine and placental blood flow. Cause for maternal hypoglycemia is not known. In women whose caloric intake is chronically low, basal glucose levels are lower than in women with adequate caloric intake, this extremely low glucose levels seem to be inadequate to maintain the gradient across the placenta. Hence, such mothers have a high chance of giving birth to low birth weight neonates. Insulin is believed to be the fetal growth hormone and it is partly regulated by fetal glucose levels that are in turn determined by the glucose gradient between the maternal and fetal compartments. Thus maternal hypoglycemia would lead to fetal hypoglycemia and fetal hypoinsulinemia and possibly fetal growth restriction. Thus, more severe the hypoglycemia, greater is likelihood of SGA neonates. Several studies have been undertaken to correlate low maternal plasma glucose after a GCT or GTT with low birth weight and adverse pregnancy outcomes. Many have shown an increase in delivery of a small for gestational age neonate and increase in adverse perinatal outcomes, such as neonatal hypoglycemia, fetal death, etc.
In a study done by Abell and Beischer, 2 the incidence of SGA was 12.8% when one hypoglycemic value was present and an incidence of 18.4% when more than one hypoglycemic value was present in patients who underwent GTT in the third trimester of pregnancy. Study done by Victor A Kouzami 3 showed an incidence of 15% of LBW IUGR in the presence of hypoglycemia. The same association was noted in a study done by JL Bienstock 4 in which 27/207 (13%) neonates whose mothers had low GCT were SGA compared with 23/369 (6.2%) with a normal GCT which was statistically significant. Leela Raman 5 et al studied the effect of maternal levels of fasting blood glucose on fetal outcome. They noted that 40% of the mothers with low glucose levels gave birth to SGA neonates. In a study done by Gustavo Lugo, 6 hypoglycemia was noted as the cause of intrauterine growth retardation in 26/211 (12%) patients. Our study also showed statistically significant incidence of SGA in the low GCT Patient with low GCT value may have either a lower baseline blood sugar level, a hyperactive insulin response or their dietary intake from either food type or meal spacing may foster lower blood sugar levels. Neonatal hypoglycemia can cause irritability, apnea and tachypnea which could be interpreted as either respiratory distress or sepsis. This may be one of the possible causes of increased NICU admission. In our study, hypoglycemia was seen only in 1.3% (2/150) of neonates of low GCT.
In the study done by Leela Raman, nine still births occurred to mothers with blood glucose levels ≤44 mg/dl and three still births to mothers with normal blood glucose levels. Neonatal deaths in our study were incidental, not related to maternal glucose levels.
As we have matched both subjects and controls with regards to socioeconomic status, BMI, interval between pregnancies, hemoglobin and subsequent weight gain, it is less likely that dietary intake is the cause for hypoglycemia. Therefore, further research is required why few women have exaggerated hypoglycemia after challenging with glucose.
A possible limitation of our study is that only one GCT value done between 24 to 28 weeks was included. Reproducibility of the test by repeating it after 3 to 7 days or consistency of hypoglycemia by repeating the test at 32 to 34 weeks when maximum fetal growth occurs was not assessed. Similar study can be performed by using fasting/postprandial blood sugars rather than challenging with glucose to know, if the growth lag is due to maternal hypoglycemia per se.
CONCLUSION
Prevalence of SGA neonate was significantly higher in women with low GCT compared to women with normal
